title: Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive urgency: a randomized, control trial.
abstract: Hypertensive urgency is defined as a severe elevation of blood pressure (BP) without target organ damage. In emergency room, hypertensive urgency has been conventionally managed by antihypertensive medication. However, there has been increasing concern for the safety of antihypertensive medication in hypertensive urgency. Thus, this study was to compare the clinical efficacy of resting and antihypertensive medication in managing hypertensive urgency.
  
  
  
  For 138 hypertensive urgency patients admitting in emergency room of Veterans Health Service (VHS) medical center, a single-center, randomized controlled trial was conducted. Hypertensive urgency patients were randomly allocated into one group out of resting group and antihypertensive medication (telmisartan) group at admission. We serially checked their BP every 30 min for 2 h, and evaluated change levels and decline of BP. Primary end point of the study was mean BP reduction from 10 to 35%. Additionally, change and decline of SBP and DBP were serially compared over 2 h.
  
  
  
  The rate of individuals approaching primary end point was 68.5% in rest group and 69.1% in medication group (P = 0.775). The change levels of BP for 2 h had no significant difference in SBP (P = 0.882) and DBP (P = 0.411) between resting group and medication group. The decline of BP after 2 h also did not show any statistical difference in both SBP (P = 0.065) and DBP (P = 0.032) between both groups.
  
  
  
  There was no significant difference between resting and antihypertensive medication in reducing BP of hypertensive urgency patients. This finding suggests the clinical efficacy of resting in managing hypertensive urgency.
authors.affiliation: aCenter for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, School of Medicine, Sungkyunkwan University bDepartment of Internal Medicine, VHS Medical Center, Seoul cDepartment of Occupational and Environmental Medicine, Dankook University, Cheonan, South Korea.
authors.forename: Sung Keun
authors.initials: SK
authors.lastname: Park
authors.forename: Dong-Young
authors.initials: DY
authors.lastname: Lee
authors.forename: Won Joong
authors.initials: WJ
authors.lastname: Kim
authors.forename: Sang Yoon
authors.initials: SY
authors.lastname: Lee
authors.forename: Hyun Sun
authors.initials: HS
authors.lastname: Park
authors.forename: Hae Won
authors.initials: HW
authors.lastname: Kim
authors.forename: Beom
authors.initials: B
authors.lastname: Kim
authors.forename: Kyoung Hyoub
authors.initials: KH
authors.lastname: Moon
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D001565:Benzoates / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D018660:Blood Pressure Monitoring, Ambulatory; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012146:Rest / Q000502:physiology*; D000077333:Telmisartan; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D000077333:Telmisartan